While investigators share their latest data in about 6,100 scientifically diverse presentations with nearly 18,000 registered attendees at the 101st annual meeting of the American Association for Cancer Research, a few prominent themes had surfaced by day three in DC — namely, cancer is more complex than was once anticipated and it’s likely time to re-think the design and execution of clinical trials.